Lassa fever case in Paris: what you need to know 13 May 2024 4 min read verified Cross-postsLassa fever
How Africa is moving towards a homegrown response to health emergencies 13 May 2024 5 min read verified Made in AfricaVaccine manufacturing
From the pain of Ebola to the passion to fight Lassa 29 Apr 2024 7 min read verified Cross-postsEbolaLassa fever
Herd(er) immunity: anthrax vaccine blunts seasonal outbreak in Zimbabwe 28 Feb 2024 6 min read verified One healthClimate changeOutbreaks
African Vaccine Manufacturing Accelerator: breaking the cycle of disadvantage 14 Dec 2023 4 min read verified Vaccine manufacturing
The African Vaccine Manufacturing Accelerator: what is it and why is it important? 7 Dec 2023 8 min read verified Vaccine manufacturing
Drier, hotter, rattier: as the weather shifts, Nigeria braces for Lassa fever 29 Nov 2023 7 min read verified Lassa feverClimate change
China, India, Brazil: Learning from the pathfinders 13 Oct 2023 7 min read verified Cross-postsMarket shapingVaccine manufacturing
Livestock herders, health authorities and butchers join forces to halt anthrax spread in Nigeria 2 Oct 2023 8 min read verified One healthOutbreaks
Toddlers, camels, goats, and cows: it’s vaccination day in Turkana 26 Sep 2023 7 min read verified Routine immunisationOne health
The view from the frontline: how Nigeria is handling resurgent Lassa fever 12 Apr 2023 6 min read verified Lassa feverOutbreaks
Ramping up Africa’s vaccine manufacturing capability is good for everyone. Here's why 18 Oct 2022 6 min read verified Cross-postsVaccine manufacturingCOVID-19
As CEPI ramps up vaccine research, a new study warns Lassa fever is set to expand its reach across Africa 17 Oct 2022 8 min read verified Cross-postsClimate changeLassa fever
Japan invests to ensure pandemic vaccines can be made in 100 days 5 Oct 2022 3 min read verified Vaccine developmentCOVID-19Vaccine manufacturing
7 COVAX innovations that could help us fight the next pandemic 20 Sep 2022 7 min read verified COVAXInnovationVaccine manufacturingVaccine developmentVaccine safety